NasdaqCM - Nasdaq Real Time Price
USD
Outlook Therapeutics, Inc. (OTLK)
0.4606
+0.0013
(+0.28%)
At close: 4:00:00 PM EST
0.4650
+0.0044
(+0.96%)
After hours: 4:29:40 PM EST
News headlines
Powered by Yahoo ScoutOutlook Therapeutics is moving from regulatory approval toward U.S. commercialization of LYTENAVA for wet age-related macular degeneration. Recent company announcements focus on strengthening commercial leadership, while earlier financial disclosures show continuing losses and substantial funding needs before launch.
